Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

GNOM 3.14
price chart
Complete Genomics Announces UK Epilepsy Society's Acquisition of Its ...
MOUNTAIN VIEW, Calif., Oct. 6, 2015 /PRNewswire/ -- Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company's newly introduced ...
Epilepsy Society becomes third customer of Complete Genomics' newly ...
BGI-Shenzhen Agrees to Buy Complete Genomics
BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics Inc. for about $117.6 million to expand in the U.S.
Chinese DNA company to buy Complete Genomics  The Deal Pipeline
Complete Genomics chief returns fire on CFIUS warning
by William McConnell In Washington | Published December 14, 2012 at 8:25 AM Complete Genomics Inc. chairman Clifford A. Reid is firing back at thwarted suitor Illumina Inc., a rival in the genome sequencing business whose executives have predicted ...
Related articles »  
Illumina, Complete Genomics Settle Patent Disputes
Law360, Los Angeles (July 18, 2013, 8:04 PM ET) -- Complete Genomics Inc. and Illumina Inc. have agreed to settle all claims in two separate patent infringement cases brought by Illumina over four of its patents, without payment being made by either ...
Related articles »  
Complete Genomics: A Leader In DNA Sequencing
Complete Genomics (NASDAQ:GNOM) was founded in 2005 and is headquartered in Mountain View, CA. It is an up and coming life sciences company that develops and commercializes an innovative DNA sequencing platform for complete human genome ...
Complete Genomics rejects Illumina bid over Chinese acquirer
Complete Genomics Inc. rejected a $123.5 million acquisition bid from Illumina Inc., a victory for potential buyer BGI-Shenzhen of China.
Photo Release -- Complete Genomics Appoints Ethan Knowlden as Senior Vice ...
MOUNTAIN VIEW, Calif., Sept. 17, 2013 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), a wholly-owned subsidiary of BGI-Shenzhen, a leading international genomics organization based in Shenzhen, China, ...
Related articles »  
Complete Genomics CEO on DNA Sequencing Capacity
30 (Bloomberg) -- Clifford Reid, chief executive officer of Complete Genomics Inc., talks about the company's genome sequencing technology and capacity outlook.
Complete Genomics: Say No To The Sale - Part 2
It's tragic that Complete Genomics (NASDAQ:GNOM) is being sold for a price that you would put on to expired aspirin. Among all the chatter that has surrounded the company subsequent to the buyout announcement, no one has said that $3.15 is a fair price.
BGI-Shenzhen Acquires US-Based Complete Genomics For $117M
19, 2013) - BGI, a genomics company based in Shenzhen, China, has successfully acquired U.S.-based whole human genomic sequencing provider, Complete Genomics, Inc., through its wholly-owned subsidiary, Beta Acquisition Corporation. BGI completed ...
Related articles »